Guidance for Neogenomics (NEO)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2024 | N/A | N/A | $650.00M – 660.00M | $632.40M | = Maintained | Details |
| 2020 | N/A | N/A | $464.00M – 474.00M | $448.30M | = Maintained | Details |
| 2019 | N/A | N/A | $379.00M – 395.00M | $385.69M | = Maintained | Details |
| 2019 | N/A | N/A | $384.00M – 400.00M | $385.00M | = Maintained | Details |
| 2018 | $0.15 – $0.20 | $0.17 | $260.00M – 272.00M | $263.90M | = Maintained | Details |
| 2018 | $0.17 – $0.19 | $0.15 | $270.00M – 272.00M | $268.13M | = Maintained | Details |
| 2018 | $0.15 – $0.20 | $0.21 | $260.00M – 270.00M | $281.06M | = Maintained | Details |
| Q3 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2017 | $0.17 – $0.21 | $0.19 | $255.00M – 265.00M | $264.60M | = Maintained | Details |
| Q4 2017 | $0.04 – $0.05 | $0.04 | $65.00M – 67.00M | $67.10M | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | $0.08 – $0.13 | ($0.22) | $242.00M – 252.00M | $244.50M | = Maintained | Details |
| 2016 | $0.07 – $0.12 | $0.07 | $240.00M – 250.00M | $243.80M | = Maintained | Details |
| 2016 | $0.14 – $0.16 | $0.13 | $245.00M – 250.00M | $247.00M |  Raised |
Details |
| 2014 | $0.05 – $0.07 | $0.07 | $73.00M – 77.00M | $72.80M | = Maintained | Details |
| Q1 2014 | $0.01 – $0.02 | $0.01 | $18.80M – 19.30M | $18.02M | = Maintained | Details |
| 2013 | $0.03 – $0.05 | $0.06 | $68.00M – 73.00M | $70.51M | = Maintained | Details |
| 2013 | $0.01 – $0.04 | $0.04 | $63.00M – 66.00M | $68.44M | = Maintained | Details |
| Q3 2013 | $0.00 – $0.01 | $0.01 | $15.80M – 16.40M | $17.56M | = Maintained | Details |
| Q1 2013 | $0.00 – $0.01 | $0.00 | $15.30M – 16.00M | $16.49M | = Maintained | Details |
